Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: J Surg Res. 2016 Jun 16;205(1):85–94. doi: 10.1016/j.jss.2016.06.022

Fig. 4.

Fig. 4

pSphK1 positive ratio in breast cancer tissue compared with HER2 overexpression. (A) pSphK1 positive ratio were determined in the patients with HER2 overexpression/amplification negative or positive. (B) Immunohistochemistry with HER2 and pSphK1 for patients with HER2 overexpression. All five cases of HER2 overexpression displayed pSphK1 negative status.